Related by context. All words. (Click for frequent words.) 70 haematologic 69 relapsed MM 69 catheter occlusion 69 CYT# potent vascular disrupting 69 oral prodrug 69 novel VDA molecule 68 K ras mutations 68 hematological parameters 68 Pharmacokinetics PK 68 administered intramuscularly 68 Ribavirin causes 68 hemorrhagic cystitis 68 severe hypersensitivity reactions 68 treatment naive genotype 68 riociguat 67 papillary renal cell carcinoma 67 Infusion Reactions Severe 67 cefazolin 67 parasitemia 67 neutropenic patients 67 interleukin IL -# 67 oral methylnaltrexone 67 hyperphenylalaninemia HPA due 67 vitamin B# folic acid 67 hypereosinophilic syndrome 67 tumor lysis syndrome 67 erythropoietic 67 MAGE A3 ASCI 67 Hypotension 67 torsade de pointes 67 SPRYCEL ® 67 Decitabine 67 kidney urologic 66 tigecycline 66 serum phosphorous 66 receiving VELCADE 66 candidemia 66 Enterobacter cloacae 66 reduce serum phosphate 66 proctitis 66 abacavir Ziagen 66 Tumor Response 66 ZOMETA 66 Thiovir 66 sitaxsentan 66 ß blockers 66 solithromycin 66 Mg Uk 66 Escherichia coli Klebsiella pneumoniae 66 CIMZIA TM certolizumab pegol 66 coagulation abnormalities 66 KETEK 66 recurrent genital herpes 66 See CLINICAL PHARMACOLOGY 66 #I TM# 66 Cardiotoxicity 66 epoetin alpha 66 Known hypersensitivity 66 headache abdominal pain 66 velafermin 66 recurrent glioma 66 Lymphocytic 66 vaginal candidiasis 66 recurrent glioblastoma multiforme 66 ORENCIA ® 66 systemic hypotension 66 TransVax ™ 66 Adenoviral 66 forodesine 66 surgical prophylaxis 66 Antitumor Activity 66 pharmacokinetic interactions 66 4mg/kg 66 Toxicities 66 Altastaph 66 liposomal amphotericin B 66 nicardipine 66 mediastinitis 66 metastatic neuroendocrine tumors 66 neutropenia dehydration dyspnea 66 including eniluracil ADH 66 intracranial hemorrhage ICH 65 metastatic malignant 65 oral antidiabetic medication 65 antibody MAb 65 pyrazinamide 65 Pafuramidine 65 polycythemia vera PV 65 CTAP# Capsules 65 mGluR5 NAM 65 vidofludimus 65 administered subcutaneously 65 Enterococcus faecium 65 HBeAg + 65 serum antibody 65 pharmacodynamic parameters 65 ritonavir boosted 65 Methylnaltrexone 65 CYP#A# CYP#D# 65 plasma pharmacokinetics 65 HBeAg negative 65 polycythemia vera essential thrombocythemia 65 receiving XGEVA 65 myopathy rhabdomyolysis 65 Aeolus Pharmaceuticals Announces 65 ganciclovir 65 elevated transaminases 65 hemoptysis 65 Atypical Hemolytic Uremic Syndrome 65 methicillin susceptible Staphylococcus aureus 65 Phase 2b Clinical Trial 65 bovine thrombin 65 pharmacodynamic PD 65 steroid refractory 65 Tasigna prolongs 65 Severe hypersensitivity reactions 65 Darinaparsin 65 methicillin resistant MRSA 65 CIMZIA ™ 65 nonhematologic adverse reactions 65 endometrial hyperplasia 65 PSMA ADC 65 8mg/kg 65 chronic eosinophilic leukemia 65 hypophosphatemia 65 Telithromycin 65 essential thrombocythemia ET 65 sotalol 65 im peramivir 65 Renal Impairment 65 MKC# MT 65 antibody titer 65 fluconazole resistant 65 Patients Treated With 65 immunocompetent 65 huC# DM4 65 nosocomial pneumonia 65 nimodipine 65 GRNCM1 65 radezolid 65 Aptivus ® 65 Tarceva TM 65 BARACLUDE ® 65 hypomagnesemia 65 selective modulator 65 generation antisense inhibitor 65 Lymphoid 65 myelodysplastic myeloproliferative diseases 65 Pegylated 65 HIV HCV coinfected 65 saline placebo 65 gastric adenocarcinoma 65 nephrotoxicity 64 QTc prolongation 64 alvespimycin 64 antiplatelet medications 64 immunomodulatory therapy 64 intradermal injections 64 methicillin sensitive 64 piperacillin tazobactam 64 CTAP# 64 immunological responses 64 invasive aspergillosis 64 Streptococcus pyogenes 64 PEGylated Fab fragment 64 nitrofurantoin 64 erlotinib Tarceva ® 64 MGd 64 omega interferon 64 myelofibrosis polycythemia vera 64 pseudomembranous colitis 64 itraconazole Sporanox 64 refractory chronic lymphocytic 64 Chronic Prostatitis 64 COPEGUS therapy 64 systemically administered 64 Hepatocytes 64 SinuNase TM 64 R Saizen R 64 Teriflunomide 64 G#DT 64 H2 antagonists 64 lenalidomide Revlimid R 64 Bacteremia 64 Patients Receiving 64 oral picoplatin 64 Candida infection 64 daptomycin 64 Naive Patients 64 BRIM2 64 replicon 64 Catheter Associated 64 cefotaxime 64 treatment naïve genotype 64 oral rivaroxaban 64 trimethoprim sulfamethoxazole 64 Hypokalemia 64 biologic DMARD 64 complement inhibitor eculizumab 64 DDP# 64 interferon gamma 1b 64 corticosteroid dexamethasone 64 BEXXAR Therapeutic Regimen 64 HCV genotypes 64 neutropenic fever 64 lenalidomide dexamethasone 64 Chronic Renal Failure 64 griseofulvin 64 bone marrow reticulin deposition 64 teriflunomide 64 abacavir lamivudine 64 trastuzumab Herceptin ® 64 allogeneic HSCT 64 VEGFR2 inhibitor 64 biliary tract cancer 64 Immunotherapeutic 64 Staphylococcus epidermidis 64 Posaconazole 64 bronchoalveolar lavage 64 budesonide foam 64 macrolide antibiotic 64 administered concomitantly 64 Mg Usa 64 included exfoliative dermatitis 64 herpes zoster shingles 64 HCV replicon 64 XP# XP# 64 neutropenia thrombocytopenia 64 Romidepsin 64 SSc 64 posaconazole 64 alkylating agent 64 herpetic keratitis 64 EGFR HER2 64 PRN FDA Approves 64 busulfan 64 orally administered inhibitor 64 cSSSIs 64 gonococcal infections 64 reactogenicity 64 SGPT 64 Gamunex C 64 bacteraemia 64 decompensated liver disease 64 myocardial infarction ventricular fibrillation 64 HIV coinfected 64 Enzastaurin 64 SPRIX ® 64 voriconazole 64 Ileus 64 potassium sparing diuretics 64 Estrogen Receptor 64 Pivotal Phase III 64 platelet dysfunction 64 tryptase 64 GLP toxicology studies 64 fosbretabulin 64 bronchodilatory 64 pheochromocytoma 64 HBeAg seroconversion 64 Valortim R 64 Pegylated Interferon 64 intravenous bisphosphonates 64 Triapine R 64 MDS MPD 64 galiximab 64 superficial bladder cancer 64 hypercalcemia 64 Warfarin Coumadin 64 pentoxifylline 64 Anthracycline 64 Nebulized 64 R lenalidomide 64 Aflibercept 64 ritonavir boosted protease inhibitor 64 Orally administered 64 MCyR 64 miconazole 64 metaplasia 64 Demonstrates Efficacy 64 DEB# 64 TO AVOID PREGNANCY WHILE 64 NMDA antagonists 64 linezolid resistant 64 Kinoid 63 thorough QT 63 hepatoma 63 hepatic insufficiency 63 docetaxel Taxotere ® 63 nonclinical studies 63 C1 INH deficiency 63 acute respiratory tract infections 63 Hedgehog Pathway Inhibitor 63 heparanase 63 vinca alkaloid 63 Allogeneic 63 rhITF 63 antineoplastic 63 Pegloticase 63 prolonged QT interval 63 Placebo Controlled Trial 63 hepatorenal syndrome 63 #mg BID [003] 63 Initiate Phase 63 NUCYNTA R 63 Navelbine ® 63 nasal decolonization 63 GOUT 63 Xelox 63 Refractory Hodgkin Lymphoma 63 peginterferon alfa 63 Fibrillex TM 63 AST ALT 63 calcineurin inhibitor 63 ribavirin USP 63 percutaneous drainage 63 osteosarcomas 63 Immunomodulatory 63 deep venous thromboses 63 corticosteroid therapy 63 Ecallantide 63 MULTAQ 63 Complicated Skin 63 Traficet EN 63 ENMD # 63 uricase 63 microbiologically evaluable 63 receptor tyrosine kinase inhibitor 63 Demonstrates Positive 63 injected subcutaneously 63 colesevelam HCl 63 investigational monoclonal antibody 63 Interferon Beta 63 nephrotoxic 63 severe oral mucositis 63 ara C 63 albiglutide 63 epithelial tumors 63 metastatic malignant melanoma 63 Bezielle 63 PAOD 63 Alphanate R 63 Ranolazine 63 eculizumab therapy 63 orally dosed 63 hyperoxaluria 63 enterococcal 63 myeloproliferative diseases 63 antimicrobial prophylaxis 63 Forodesine HCl 63 weekly subcutaneous injections 63 lactate dehydrogenase LDH 63 carcinoids 63 HCD# [002] 63 HCV SPRINT 63 Adjunctive 63 HepaGam B TM 63 Epstein Barr Virus EBV 63 leiomyomas 63 SCIg 63 gemcitabine Gemzar ® 63 naïve HCV 63 NRTI resistance 63 toenail onychomycosis 63 cidofovir 63 ALT flares 63 vancomycin resistant 63 soluble tumor necrosis 63 Antiviral Activity 63 Phase Ib study 63 proguanil 63 tolterodine ER 63 Opportunistic infections 63 PEGylated anti 63 EXJADE 63 Ophena TM 63 ACTEMRA TM 63 Gilead Viread 63 Alferon LDO 63 receiving immunosuppressive therapy 63 urocortin 2 63 hematologic toxicity 63 evaluating tivozanib 63 cisplatin resistant 63 Castration Resistant Prostate Cancer 63 anthracycline taxane 63 refractory NSCLC 63 5 HT2A inverse 63 5mg dose 63 Sapacitabine 63 Panzem R NCD 63 UPLYSO 63 Azacitidine 63 trivalent influenza vaccine 63 cMET 63 anagrelide 63 TELINTRA 63 demonstrated antitumor activity 63 metformin accumulation 63 thymectomy 63 mg q#h 63 hoFH 63 ergot derivatives 63 Pemetrexed 63 diarrhea predominant irritable 63 intravesical instillation 63 intranasal formulation 63 genotypic resistance 63 Tigecycline 63 TYGACIL 63 surgically resected 63 FUSILEV enhances 63 Cimzia TM 63 oxacillin 63 humanized interleukin 6 63 APTIVUS r 63 LHRH receptor positive 63 BPH benign prostatic 63 IOP lowering 63 inotropes 63 FOLFOX6 63 K. pneumoniae 63 salmeterol fluticasone 63 C1 Inhibitor 63 renal cysts 63 conventional DMARDs 63 follicular lymphomas 63 liver metastasis 63 chlamydial 63 anaphylactic reactions bronchospasm 63 MEK Inhibitor 63 assessing T DM1 63 G CSFs 63 Streptococcus agalactiae 63 iobenguane 63 APTIVUS 63 immune globulins 63 FOSRENOL ® 63 OMNARIS HFA 63 achieved CCyR 63 cytotoxic effects 63 undetectable HBV DNA 63 R# #mg BID 63 administered intranasally 63 invasive candidiasis 63 IMPACT DCM 63 HBV infections 63 ALN HPN 63 viral kinetics 63 cyclosporine tacrolimus 63 COPEGUS R 63 Alequel 63 TNF Tumor Necrosis Factor 63 relapsed ALL 63 FASLODEX 62 serologic testing 62 orchitis 62 visilizumab 62 maximally tolerated dose 62 ascending dose 62 benign prostatic hypertrophy BPH 62 radiolabeled TM# 62 Glucocorticoids 62 PROSTVAC VF 62 factor TNF receptor 62 Erythropoietic therapies may 62 coagulase negative staphylococci 62 MenACWY 62 Heterozygous Familial Hypercholesterolemia 62 Dasatinib 62 tolevamer 62 Certolizumab pegol 62 thrombocytosis 62 TURBT 62 HMG CoA reductase inhibitors 62 Staphylococcus aureus S. aureus 62 non splenectomized 62 prostate carcinoma 62 TRAIL induced apoptosis 62 adrenocorticotropic hormone 62 phase IIb study 62 INVEGA ® 62 bacteriuria 62 MyVax R 62 Daptomycin 62 E. faecalis 62 IgM antibodies 62 causative pathogen 62 either acutely decompensated 62 Newly Diagnosed Multiple Myeloma 62 myeloperoxidase 62 rifamycins 62 intravenous bolus 62 potassium binder 62 HGS ETR1 mapatumumab 62 Phase #b/#a trial 62 Rimantadine 62 Oral Fingolimod 62 cIAI 62 Abrupt discontinuation 62 Thalomid ® 62 prokinetic agent 62 PROMACTA 62 heparin induced thrombocytopenia 62 Achieves Primary Endpoint 62 acute GvHD 62 peripheral blood mononuclear 62 antiretroviral naive 62 infused intravenously 62 amikacin 62 colorectal liver metastases 62 Immunohistochemical analysis 62 hemagglutination inhibition HAI 62 Hypersensitivity reactions 62 alpha interferons 62 ribavirin therapy 62 receiving INTRON 62 hepatic failure 62 piroxicam 62 NS#/#A protease 62 rFVIIa 62 surgically resectable 62 unresectable tumors 62 Progenitor Cells 62 cranial irradiation 62 Relapsed Multiple Myeloma 62 FluCAM arm 62 glycopeptide 62 dose limiting toxicities 62 R sorafenib tablets 62 thalidomide Thalomid 62 Proellex TM 62 TLK# 62 cromolyn sodium 62 MIC# [001] 62 Golimumab 62 ertapenem 62 extrahepatic 62 AERx ® 62 BrachySil TM 62 ALB # 62 dopamine partial agonist 62 PROCHYMAL 62 VELCADE melphalan 62 empiric therapy 62 mild renal insufficiency 62 Diarrheal 62 PEG SN# 62 transfusion transmitted 62 pharyngitis tonsillitis 62 humanised monoclonal antibody 62 CYP#A# substrate 62 TTR amyloidosis 62 pDC 62 Trichophyton rubrum 62 APTIVUS ritonavir 62 indinavir Crixivan 62 HES CEL 62 interferon γ 62 TNF blocker therapy 62 INSPIRE Trial Phase III 62 CINTREDEKIN BESUDOTOX 62 antimuscarinic 62 β blockers 62 ISTODAX 62 oral JAK1 62 certolizumab 62 Systemic Sclerosis 62 anemia thrombocytopenia 62 Initiate Clinical Trial 62 selective phosphodiesterase 62 Peginterferon alfa 2b 62 immune globulin intravenous 62 pericardial effusion 62 pharmacokinetic PK 62 alfa 2a 62 interferon alfa 2b 62 pretransplant 62 Hsp# Inhibitor 62 skeletal metastases 62 CYC# 62 Solid Tumors 62 NAGS deficiency 62 MYCAMINE 62 aplastic anemia AA 62 ChronVac C 62 Diabetic Neuropathy 62 rabeprazole 62 ABSSSI 62 vapreotide acetate 62 OHR/AVR# 62 Randomized Phase 62 bacteremia 62 Postoperative complications 62 CK # administered 62 intravesical infusion therapy 62 HepG2 cells 62 Amgen Neulasta ® 62 Bordetella pertussis 62 PREZISTA r 62 Afatinib 62 HCV polymerase 62 subcutaneous immunoglobulin 62 Investigational Treatment 62 recurrent malignant glioma 62 Antifungal 62 telaprevir VX 62 Tyrosine Kinase Inhibitor 62 rALLy 62 Recombinant Human 62 Emtriva Viread 62 Eculizumab 62 CCX# 62 Reports Preclinical Data 62 steroid dexamethasone 62 NSAID induced 62 Androxal TM 62 Dose Ranging Study 62 5 fluorouracil leucovorin 62 NMIBC 62 induce orthostatic hypotension 62 Malignant Glioma 62 inducible nitric oxide synthase 62 acute febrile 62 MVA MUC1 IL2 62 sJIA 62 intravenous immunoglobulin 62 chills fever headache 62 B. fragilis 62 esophageal candidiasis 62 Platinol ® 62 malignancy HCM 62 MEND CABG 62 ethambutol 62 PNP inhibitor 62 Hormone Refractory Prostate Cancer 62 Aclidinium 62 histone deacetylase inhibitor 62 T1c 62 Diabetic Foot Ulcer 62 methicillin resistant S. aureus 62 CMV infection 62 null responder 62 AVELOX 62 INCB# [003] 62 Elotuzumab 62 human IgG1 monoclonal 62 IMA# 62 morphometric vertebral fractures 62 vWF 62 nucleotide analog 62 Gastrointestinal Stromal Tumors 62 CINQUIL 62 d l leucovorin 62 delafloxacin 62 nucleoside analog 62 meropenem 62 icatibant 62 Hepatocellular Carcinoma HCC 62 topical gel formulation 62 intravesical 62 AAG geldanamycin analog 62 Plicera 62 Telbivudine 62 peripherally acting 62 antiretroviral naïve 62 LEP ETU 62 Cethromycin 62 acute humoral rejection 62 S/GSK# 62 adalimumab Humira 62 azacytidine 62 Simulect 62 Arikace 62 HDAC Inhibitor 62 beta lactam antibiotic 62 dose cohort 62 mutated K ras 62 HCV Genotype 62 NUCYNTA ™ 62 CR# vcMMAE 62 CYT# QbG# 62 dasatinib Sprycel ® 62 mg/m2 cohort 62 squalamine 62 CANCIDAS 62 receptor inhibitor 62 parenterally administered 62 Hurthle cell 62 quinolone antibiotics 62 EDEMA3 trial 62 sodium thiosulfate STS 62 severe dermatologic toxicities 62 Lubiprostone 62 Cariprazine 62 PROCRIT ® 62 alefacept 62 Amgen Neulasta R 62 2 methoxyestradiol 62 BAL# [002] 62 systemic corticosteroid 62 pleurodesis 62 postoperative morbidity 62 Eltrombopag 62 cystic fibrosis chronic pancreatitis 62 LEUKINE 62 APTIMA HPV assay 62 Multiple Ascending Dose 62 Personalized Immunotherapy 62 RSV replication 62 AKT inhibitor 62 arteritis 62 immunohistochemical 62 protein tyrosine phosphatase 1B 62 cardiovascular calcification 62 Xanafide 62 Umbilical cord stem cells 62 GVAX ® 62 taxane resistant 62 pyridostigmine 62 Cytotoxic 62 Intravenous immunoglobulin 62 LB# [003] 62 hydroxocobalamin 62 Cell Lymphoma CTCL 62 multicenter Phase III 62 Epidermal Growth Factor Receptor 62 4CMenB 62 Evoltra ® 62 r hGH 62 NTCD 62 trastuzumab DM1 T DM1 62 dose escalation phase 62 ribavirin RBV 62 denileukin diftitox 62 BENICAR HCT 62 crizotinib PF # 62 huN# DM1 62 Dendritic Cells 62 immunocompetent patients 62 aripiprazole Abilify 62 Phase #/#a 62 atypical hemolytic uremic syndrome 62 pharmacokinetic PK study 62 5 HT3 antagonist 62 HyQ 62 oral nucleoside analogue 62 immunomodulation 62 immunomodulatory properties 62 ELACYT 62 DMARDS 61 brand ciclesonide HFA 61 5mg/kg 61 lichen planus 61 HGS ETR2 61 tipranavir ritonavir 61 Chemokine Receptor 61 acyclovir Zovirax 61 H. influenzae 61 Gleevec resistant 61 Kamada AAT 61 INTEGRILIN R 61 pharmacodynamic effects 61 nasopharyngeal swabs 61 bleomycin 61 e antigen HBeAg 61 Aplidin R 61 statin monotherapy 61 brivaracetam 61 Spectrum Pharmaceuticals Announces 61 Leukemias 61 Maribavir 61 PRADAXA 61 antiemetics 61 recombinant PSMA vaccine 61 antiandrogen 61 5alpha reductase 61 lead Aganocide compound 61 Pelvic Inflammatory Disease 61 phenothiazines 61 Dacogen injection 61 Indomethacin 61 aspartate aminotransferase 61 Kahalalide F 61 colorectal adenocarcinoma 61 refractory gout 61 intra articular injection 61 dasatinib Sprycel 61 Antithrombin 61 Teriparatide 61 Valortim ® 61 Parnate 61 Mycophenolate Mofetil 61 concomitant antibiotics 61 prostanoid 61 thrombocytopenic 61 polymicrobial 61 small molecule tyrosine 61 sunitinib Sutent 61 rheumatoid arthritis osteoarthritis ankylosing 61 LAB CGRP 61 CIMZIA TM 61 micafungin 61 Combination REOLYSIN R 61 immune reconstitution syndrome 61 VEGF inhibitors 61 ANCA associated 61 dosing cohort 61 ORENCIA R 61 postexposure prophylaxis 61 Cerebril TM 61 Insulin PH# 61 oral vancomycin 61 Pooled Analysis 61 GnRH agonists 61 DLTs 61 CIMZIA R 61 Civacir 61 chronic thromboembolic pulmonary 61 ® lenalidomide 61 non constipating irritable 61 6 mercaptopurine 61 Cervical Dysplasia 61 Late Breaker 61 angioneurotic edema 61 Meets Primary Endpoint 61 Th2 cytokines 61 Progressive Multifocal Leukoencephalopathy 61 zoledronate 61 gonococcal 61 Relapsed Refractory Multiple Myeloma 61 keloid scarring 61 Relapsing Multiple Sclerosis 61 Pivotal Phase 61 Platinol ® cisplatin 61 Rigel R# 61 clevidipine 61 NNRTI resistant virus 61 Chemophase 61 severe hypercholesterolemia 61 systemic immunosuppressive drugs 61 SinuNase ™ 61 CYP #D# 61 fluvastatin 61 treat chronic sinusitis 61 efavirenz EFV 61 ZOLINZA 61 Capecitabine 61 Recurrent Glioblastoma 61 calcineurin inhibitors 61 hemorrhagic colitis 61 renal toxicity 61 microgram kg 61 Dacogen decitabine 61 preclinical efficacy 61 eosinophilic pneumonia 61 Rhinocort 61 NATRECOR ® 61 complete cytogenetic response 61 coinfected patients 61 malignant ascites 61 Phase IIa Clinical Trial 61 oral beclomethasone dipropionate 61 diphtheria pertussis whooping cough 61 adrenocortical cancer 61 SNT-MC#/idebenone 61 prochlorperazine 61 histone deacetylase HDAC inhibitor 61 Xcytrin R 61 oxaliplatin Eloxatin 61 primidone 61 YONDELIS 61 NPH insulin 61 liver decompensation 61 sorafenib tablets 61 Atripla combines 61 lamivudine resistant 61 anthracycline chemotherapy 61 ChronVac C R 61 fallopian tube cancers 61 immuno modulatory 61 Cloretazine 61 metastatic colorectal carcinoma 61 Severe Sepsis 61 ARCALYST ® 61 AMEVIVE 61 Clinical Trial Results 61 Secretase 61 antibiotic amikacin 61 imatinib Gleevec ® 61 hepatocellular carcinomas 61 candida albicans 61 transrectal ultrasound guided 61 2 inhibitor CYT# 61 postexposure 61 Zorbtive TM 61 injectable formulations 61 bacterium Mycobacterium tuberculosis 61 panitumumab Vectibix 61 thymidine kinase 61 potent CYP#A# inhibitors 61 arsenic trioxide injection 61 CCR5 antagonist 61 inhalation powder 61 NS5b 61 degranulation 61 sunitinib Sutent ® 61 conserved antigens NP 61 tumor xenograft models 61 imatinib therapy 61 Trofex 61 antiangiogenic agent 61 HQK 61 Immunogenicity 61 HepaGam B 61 Immunohistochemical staining 61 Nilotinib 61 antibiotic regimens 61 Transdermal Patch 61 S. aureus isolates 61 Lenocta 61 fumagillin nanoparticles 61 opportunistic pathogens 61 highly immunogenic 61 GAMMAGARD 61 CMV infections 61 immune modulating 61 hA# 61 JAK2 enzyme 61 INVANZ 61 fluticasone furoate 61 Pseudomonas aeruginosa infections 61 Hepatotoxicity 61 candidates Azedra TM 61 CMV seropositive 61 Phase 2b Study 61 bisoprolol 61 associated diarrhea CDAD 61 inflammatory autoimmune diseases 61 Potent Inhibitor 61 indinavir 61 hMG 61 #beta estradiol 61 Poly ICLC 61 endothelial activation 61 Vitro Activity 61 containing abacavir 61 suppressive therapy 61 CYP #A# 61 cisplatin gemcitabine 61 AEG# 61 pyrimidine nucleoside analog 61 Abscesses 61 HBV vaccine 61 cytomegalovirus infection 61 norfloxacin 61 Pruvel 61 Tolvaptan 61 pamidronate 61 pituitary adenomas 61 prostate cancer metastases 61 moderate hepatic impairment 61 LymphoStat B TM 61 serologic tests 61 unknown etiology 61 Comorbidities 61 anemia neutropenia 61 non nucleoside 61 CCR5 mAb 61 Inhalation Solution 61 Fungal Infections 61 Cleviprex TM clevidipine 61 HCV RESPOND 2 61 hyaluronidase enzyme 61 Staphylococcal 61 Tacrolimus 61 Phase 2a Clinical Trial 61 Preclinical Data 61 caspofungin 61 Epratuzumab 61 varicella zoster virus VZV 61 GH deficiency 61 Shigatoxin producing E. coli 61 pyrexia mucositis sepsis febrile 61 multicenter randomized placebo controlled 61 florbetaben 61 systemic RNAi therapeutic 61 hepatocellular 61 Corynebacterium 61 Mycoplasma pneumoniae 61 hyperammonemia 61 Initiates Phase II 61 develop HBV reactivation 61 bFGF 61 Humanized Anti 61 ano genital warts 61 novel emulsion formulation 61 miconazole Lauriad ® 61 herpesviruses